Trial Details
Not RecruitingBasic Information
| Clinical ID | c2210 |
|---|---|
| Identifier | IRCT20101107005123N3 |
| Trial Title | Evaluation of the effect of silymarin in patients with inflammatory bowel disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Inflammatory Bowel Disease. Noninfective inflammatory bowel disease;K50-K52 |
| Interventions | Intervention 1: Intervention group: Silymarin tablets (Gol Daro Company) with a dose of 5 mg/kg in divided doses three times a day for three months on a daily basis. Intervention 2: Control group: Three times a day placebo for three months on a daily basis. |
Participant Information
| Sponsor | Mashhad University of Medical Sciences |
|---|---|
| City | - |
| Country/Region | Iran |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, CHILD, TEENAGER |
Study Design
| Study Type | interventional |
|---|---|
| Phase | Not Available |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |